Related Experiment Video
Updated: Dec 19, 2025
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular Risk Factor Modification in Asymptomatic Adults and Implications for Pilots
I Made Ady Wirawan1, Robin F Griffiths2, Peter D Larsen2
1Department of Public Health and Preventive Medicine, Faculty of Medicine, Udayana University.
Abstract:
This study aims to examine the available evidence that supports a more aggressive approach to managing asymptomatic people with low to intermediate cardiovascular risks; to evaluate the appropriate threshold for initiating pharmacologic interventions to treat hyperglycaemia, hyperlipidaemia, and hypertension; and to describe the implications for airline pilots. A systematic search was performed employing an OvidSP interface, including all EBM Reviews, EMBASE, and Ovid MEDLINE databases. Data, including sixteen randomised controlled trials, on the appropriate threshold for initiating pharmacologic interventions were extracted. Studies on the treatment of hyperlipidaemia indicated that the threshold for initiation of intervention in intermediate-risk people is a LDL-C level of 3.36 mmol/l (130 mg/dl). There was no lower limit or optimal LDL-C level below which further reduction was no longer beneficial. Studies on the treatment of hyperglycaemia suggested that a threshold of fasting plasma glucose of ≥5.3 mmol/l (95 mg/dl) and 2-hour postprandial glucose level of 7.8 mmol/l (140 mg/dl) is reasonable for initiating pharmacologic intervention. Initiating treatment to people with a blood pressure of ≥130/≤89 mmHg or ≤139/≥85 mmHg significantly reduced the risk of developing stage 1 hypertension. Multifactorial intervention studies showed that, in hypertensive patients (BP ≥160/≥100 mmHg), initiating treatment to those with a total cholesterol of 6.5 mmol/l (251.35 mg/dl) or higher resulted in a significant reduction in the risk of developing fatal and non-fatal cardiovascular events. The available evidence from large quality trials supports a more aggressive approach to managing hyperglycaemia, hyperlipidaemia, and hypertension in asymptomatic pilots with a 5-year CVD risk of 5-10% and 10-15%.
Insights
This study suggests an aggressive management approach for asymptomatic individuals with low to intermediate cardiovascular risks, focusing on specific thresholds for treating high blood sugar, cholesterol, and blood pressure to prevent cardiovascular events.
Area of Science:
- Cardiology
- Preventive Medicine
- Aviation Medicine
Background:
- Cardiovascular disease (CVD) risk management in asymptomatic individuals, particularly airline pilots, requires updated evidence-based thresholds for intervention.
- Current guidelines may not fully address the nuances of managing multiple risk factors like hyperglycaemia, hyperlipidaemia, and hypertension in this specific population.
- Airline pilots, due to occupational demands, necessitate a clear understanding of CVD risk and management strategies.
Purpose of the Study:
- To evaluate evidence supporting a more aggressive management strategy for asymptomatic individuals with low to intermediate cardiovascular risks.
- To determine appropriate thresholds for initiating pharmacologic interventions for hyperglycaemia, hyperlipidaemia, and hypertension.
- To outline the implications of these findings for the health management of airline pilots.
Main Methods:
- A systematic literature search was conducted using OvidSP, encompassing EBM Reviews, EMBASE, and Ovid MEDLINE databases.
- Data extraction focused on randomized controlled trials (RCTs) and observational studies concerning intervention thresholds.
- Key parameters analyzed included LDL-cholesterol, fasting and postprandial glucose levels, blood pressure, and total cholesterol in relation to CVD event reduction.
Main Results:
- For hyperlipidaemia, an LDL-C level of 3.36 mmol/l (130 mg/dl) is indicated for intervention in intermediate-risk individuals.
- Pharmacologic intervention for hyperglycaemia is suggested at fasting plasma glucose ≥5.3 mmol/l (95 mg/dl) or 2-hour postprandial glucose ≥7.8 mmol/l (140 mg/dl).
- Blood pressure management initiated at ≥130/≤89 mmHg or ≤139/≥85 mmHg significantly reduces the risk of developing stage 1 hypertension; for hypertensive patients (BP ≥160/≥100 mmHg), a total cholesterol of ≥6.5 mmol/l (251.35 mg/dl) warrants intervention.
Conclusions:
- Evidence supports a more aggressive management of hyperglycaemia, hyperlipidaemia, and hypertension in asymptomatic pilots with a 5-year CVD risk of 5-15%.
- Implementing these evidence-based thresholds can lead to significant reductions in cardiovascular events.
- Proactive management tailored to specific risk profiles is crucial for maintaining pilot health and aviation safety.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
01:26Atherosclerosis III: Management
01:30Coronary Artery Disease I: Introduction
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:20Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT